DDMoRe meeting

DDMoRe, sharing knowledge to improve drug development

The Drug Disease Model Resources (DDMoRe) consortium has been created to improve the quality, efficiency and cost effectiveness of model-informed decisions in drug development and therapeutic use of marketed drugs.

The platform will deliver consistency of evidence that industry and health authorities can rely on in making decisions about development and approval of new medicines. It will also be a resource for academic research and improvement of therapy with existing drugs. Information from a wide array of sources can be integrated into models to describe and predict the behavior of complex disease/biological systems and drug actions.


DDMoRe’s products

DDMoRe’s products deliver an open source, integrated framework to enable Model Informed Drug Discovery & Development:

Model Repository

An open, publicly available, free-to-use model repository. Based on the developed standards Pharmacomtrics Markup Language and Modelling Description Language, the repository will enable sharing and re-use of models.

Interoperability Framework

An integrated infrastructure to enable efficient exchange and integration of models across modelling languages, existing and new tools.


Support education and training in DDMoRe’s products and their use in drug/disease Modelling and Simulation.

Postponed DDMoRe course: Model-Informed Drug Development Oncology Advanced

DDMoRe consortium continues a series of comprehensive face-to-face courses introducing the principles of model-informed drug development, covering a range of therapeutic areas, via the newly-developed DDMoRe interoperability framework platform. 

The Bioinformatics, Mathematical Modeling and Synthetic Biology  (BMS) lab at Università degli Studi di Pavia, Italy and the Institute of Pharmacy, Freie Universitaet Berlin, Germany are happy to invite you to the following face-to-face course:

Read more

© 2012 | DDMoRe, all rights reserved.